Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Direvo Validates BluZy™ Technology in Collaboration with US CCUR

Published: Friday, December 21, 2012
Last Updated: Friday, December 21, 2012
Bookmark and Share
Company has successfully completed the scale up of BluZy™-D and BluZy™-P.

Direvo Industrial Biotechnology GmbH has successfully completed the scale up of its first two products BluZy™-D and BluZy™-P in collaboration with the Center for Crops Utilization Research (CCUR) and the BioCentury Research Farm (BCRF) at Iowa State University.

A team led by Dr. Larry Johnson, director of CCUR and BCRF, conducted lab-scale and pilot-scale trials to test the effects of the enzyme technology on ethanol production and processed samples of enzyme-modified DDGS and unmodified DDGS for analytical and nutritional comparison purposes.

From this work, Direvo validated the performance of BluZy™-D that substantially improved nutritional value as compared to commercially available DDGS.

The production was further scaled up at BCRF where more than one ton of DDGS was produced for further evaluation in broiler feeding trials at major universities in the US.

BluZy™-P the second product of Direvo´s BluZy™ product development platform was also evaluated by the experts at BCRF. BluZy™-P improved process efficiency of ethanol production at multiple steps and significantly simplified back end oil separation.

“The pilot-scale facilities for dry-grind ethanol production at BCRF offered Direvo the ideal opportunity to test this new and unique technology prior to full-scale production,” said Klaudija Milos, Vice President Business Unit Industrial Solutions.

Milos continued, “Our recent project results demonstrate the validity of our technologies and the economic benefit for two large industries in the US, ethanol and animal production.”

Direvo will be exploring various industry opportunities as it proceeds in scaling up the BluZy™-Technology for commercial operations.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

European and US Cellulase Patents Granted to Direvo
Granted patents describe improved cellulase enzymes having CBH II activity.
Wednesday, May 22, 2013
Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!